Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 30;2013(4):354-6.
doi: 10.5339/gcsp.2013.41. eCollection 2013.

ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation

Riyaz A Kaba, Omar Ahmed  1 , Douglas Cannie  2
Affiliations

ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation

Riyaz A Kaba et al. Glob Cardiol Sci Pract. .
No abstract available

PubMed Disclaimer

References

    1. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Perekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151. - PubMed
    1. Patel MR, Mahaffrey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SF, Fox KA, Califf RM, ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891. - PubMed
    1. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomeno A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992. - PubMed
    1. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, S˘pinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, ENGAGE AF-TIMI 48 Investigators Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2013;369:2093–2104. - PubMed
    1. Kaba RA, Camm AJ, Williams TM, Sharma R. Managing atrial fibrillation in the global community: The European Perspective. GCSP. 2013:24. http://dx.doi.org/10.5339/gcsp.2013.24. - DOI - PMC - PubMed

LinkOut - more resources